Related Experiment Video
Updated: Aug 9, 2026
07:17
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Hairy cell leukemia: an interferon deficient disease?
Cancer Treatment Reviews
|December 1, 1985
Summary
Recombinant interferon-alpha 2 (rIFN-alpha 2) effectively treats hairy cell leukemia (HCL), significantly improving blood counts in most patients. Maintenance therapy with rIFN-alpha 2 can sustain these improvements long-term.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Hairy cell leukemia (HCL) is a rare lymphoproliferative disorder characterized by profound cytopenias.
- Current treatments for HCL have limitations, necessitating exploration of novel therapeutic agents.
Purpose of the Study:
- To evaluate the efficacy and optimal dosing of recombinant interferon-alpha 2 (rIFN-alpha 2) in patients with HCL.
- To investigate the potential mechanisms of action for rIFN-alpha 2 in HCL treatment.
Main Methods:
- A cohort of 13 HCL patients received rIFN-alpha 2 treatment.
- Treatment duration, response in peripheral blood counts, and maintenance therapy were assessed.
Main Results:
- Twelve out of 13 patients achieved significant improvement in profound cytopenias.
- A median treatment duration of approximately 2 months was required for response.
- Maintenance therapy with rIFN-alpha 2 every other week was sufficient to sustain improved cell counts.
Conclusions:
- rIFN-alpha 2 is an effective treatment for HCL, inducing dramatic hematological improvements.
- The mechanism may involve addressing an interferon deficiency in HCL, potentially related to depressed monocyte function.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...